1H NMR spectroscopy of ascitic fluid: Discrimination between malignant and benign ascites and comparison of the results with conventional methods

NMR in Biomedicine

Volumn 21, Issue 6, 2008, Pages 606-614

  Bala, Lakshmi ^a   Sharma, Abhinav ^a   Yellapa, Radha Krishna ^a   Roy, Raja ^a   Choudhuri, G ^a   Khetrapal, C L ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Ascitic fluid; Benign; Biochemicals; Body fluid; Cirrhosis; Malignant; Proton NMR; Serum ascitic albumin gradient

Indexed keywords

ASCITIC FLUID; BENIGN; BIOCHEMICALS; BODY FLUID; CIRRHOSIS; MALIGNANT; PROTON NMR; SERUM ASCITIC ALBUMIN GRADIENT;

3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID; ACETONE; ALANINE; ALBUMIN; CITRIC ACID; FORMIC ACID; GLUCOSE; GLUTAMINE; HISTIDINE; LACTIC ACID; PHENYLALANINE; PYRUVIC ACID; TYROSINE;

ABDOMINAL TUMOR; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASCITES FLUID ANALYSIS; ASCITES FLUID CYTOLOGY; CIRRHOTIC ASCITES; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT ASCITES; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ASCITES; ASCITIC FLUID; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 48349087619     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1232     Document Type: Article

References (36)

1. Light RW. Approach to the patient. In Pleural Diseases, Light RW (ed). Lea and Febiger: Philadelphia, 1990; 75-83.
2. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8: 1104-1109.
3. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-1157.
4. Pockros PJ, Esrason KT, Nguyen C, Duque J, Woods S. Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology 1992; 103: 1302-1306.
5. Aslam N, Marino CR. Malignant ascites: new concepts in pathophysiology, diagnosis and management. Arch. Intern. Med. 2001; 161: 2733-2737.
6. Yazdi GP, Miedema BW, Humphrey LJ. High mortality after abdominal operation in patients with large-volume malignant ascites. J. Surg. Oncol. 1996; 62: 93-96.
7. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann. Intern. Med. 1992; 117: 215-220.
8. Pare P, Talbot J, Hoefs JC. Serum-ascitic albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites. Gastroenterology 1983; 85: 240-244.
9. Rector WG Jr, Reynolds TB. Superiority of serum-ascites albumin difference over the ascites total protein concentration in separation of 'transudative' and 'exudative' ascites. Am. J. Med. 1984; 77: 83-85.
10. Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J. Lab. Clin. Med. 1983; 102: 260-273.
11. Spriggs AI, Boddington MM. Atlas of serous fluid cytopathology. A guide to the cells of pleural, pericardial, peritoneal and hydrocele fluids. In Current Histopathology Series, volume 14, Gresham GA (ed). Kluwer Academic Publishers: Dordrecht, 1989; 1-10.
12. Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U, Bocking A. Diagnostic accuracy of effusion cytology. Diagn Cytopathol. 1999; 20: 350-357.
13. Alexandrakis MG, Moschandrea JA, Koulocheri SA, Kouroumalis E, Eliopoulos GD. Discrimination between malignant and non-malignant ascites using serum and ascitic fluid proteins in a multivariate analysis model. Dig. Dis. Sci. 2000; 45: 500-508.
14. Alexandrakis MG, Moschandrea J, Kyriakou DS, Alexandraki R, Kouroumalis E. Use of a variety of biological parameters in distinguishing cirrhotic from malignant ascites. Int. J. Biol. Markers 2001; 16: 45-49.
15. Rana SV, Babu SGV, Kocchar R. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites. Med. Sci. Monit. 2005; 11: CR136-142.
16. Trape J, Molina R, Sant F. Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusions. Tumour Biol. 2004; 25: 276-281.
17. Chang HW, Ali SZ, Cho SK, Kurman RJ, Shih IeM. Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis. Clin. Cancer Res. 2002; 8: 2580-2585.
18. 1H NMR spectroscopic method for the diagnosis of malabsorption syndrome: a pilot study. NMR Biomed. 2004; 17: 69-75.
19. 1H NMR spectroscopy. Magn. Reson. Med. 2006; 56: 738-744.
20. Lindon JC, Nicholson JK, Everett JR. NMR spectroscopy of biofluids. Ann. Rep. NMR Spectrosc. 1999; 38: 1-88.
21. Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch. Intern. Med. 1986; 146: 2259-2261.
22. Runyon BA. Approach to the patient with ascites. In Text Book of Gastroenterology, Vol I, 3rd edn, Yamada T, Alpers David A, Laine L, Owyang C, Powell DW (eds). Lippincott Williams and Wilkins Publishers: Philadelphia, 1999; 966-991.
23. Meiboom S, Gill D. Modified spin echo method for measuring nuclear relaxation time. Rev. Sci. Instrum. 1958; 29: 688-691.
24. Derome A, Williamson M. 2D homonuclear shift correlation phase sensitive using TPPI with double quantum filter phasecycle. J. Magn. Reson. 1990; 88: 177-185.
25. Bax A, Davis DG. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 1985; 65: 355-360.
26. Lehninger AL. Principles of Biochemistry. WH Freeman and Co: New York, 2000.
27. Norusis MJ (ed). SPSS/PC Advanced Statistics Manual. SPSS Inc: Chicago, 1990.
28. Armitage P (ed). Statistical Methods in Medical Research, 1st edn. Blackwell Scientific Publications: Oxford, 1971; 351-355.
29. Lachenbruch PA, Goldstein M. Discriminant analysis. Biometrics 1979; 35: 69-85.
30. Everitt BS, Dunn G. Applied Multivariate Data Analysis. Edward Arnold: London, 1991.
31. Wenner CE. Regulation of energy metabolism in normal and tumor tissues. In Cancer: A Comprehensive Treatise. Plenum Press: New York, 1975; 389-403.
32. Racker E. Why do tumor cells have high aerobic glycolysis? J. Cell Physiol. 1976; 89: 697-700.
33. Leach M, Moyec L, Podo F. MRS of tumors: basic principles. In Magnetic Resonance Spectroscopy in Biology and Medicine: Functional and Pathological Tissue Characterization, De Certaines JD, Bovee WMMJ, Podo F (eds). Pergamon Press: New York, 1992; 295-344.
34. Costello LC, Franklin RB. 'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis. Mol. Cell Biochem. 2005; 30: 1-8.
35. Montanari A, Simoni I, Vallisa D, Trifiro A, Colla R, Abbiati R, Borghi L, Novarini A. Free amino acids in plasma and skeletal muscle of patients with liver cirrhosis. Hepatology 1988; 8: 1034-1039.
36. Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW. Aromatic amino acid metabolism during liver failure. J. Nutr. 2007; 137: 1579S-1585S.